Today: 23 March 2026
Browse Category

Stock Market 31 December 2025

Why Netflix stock is up today: Warner Bros. board seen sticking with Netflix deal

Why Netflix stock is up today: Warner Bros. board seen sticking with Netflix deal

Netflix shares rose 0.4% to $94.19 in midday trading Wednesday as Warner Bros. Discovery signaled it will likely reject Paramount Skydance’s revised $108.4 billion bid, keeping Netflix’s $82.7 billion offer in play. Warner’s board is set to meet next week. Netflix agreed December 5 to buy Warner’s studios and streaming assets in a cash-and-stock deal. Volume topped 10 million shares.
31 December 2025
Intel stock today edges higher after Nvidia’s $5 billion stake filing — what investors watch next

Intel stock today edges higher after Nvidia’s $5 billion stake filing — what investors watch next

Intel confirmed it sold 214.8 million shares to Nvidia for $5 billion in cash, according to a regulatory filing. Intel shares edged up 0.2% to $37.39 in midday trading. The deal, completed Dec. 26, was a private placement under a September agreement. Investors are watching how Intel will use the new funds as it expands manufacturing.
Ondas Holdings (ONDS) stock jumps today after $10 million autonomous systems order haul

Ondas Holdings (ONDS) stock jumps today after $10 million autonomous systems order haul

Ondas Holdings shares jumped 11.9% to $10.06 by midday after the company reported about $10 million in new autonomous systems orders from government and infrastructure clients. The company also cited $16.4 million in fourth-quarter orders for counter-drone systems at European airports. Investors are watching for follow-on orders in January and additional share issuance flagged in a recent SEC filing.
31 December 2025
AAON stock slips even after credit line boost to $600 million — what Wall Street is watching next

AAON stock slips even after credit line boost to $600 million — what Wall Street is watching next

AAON shares dropped 2.7% to $76.48 by midday after the company expanded its revolving credit facility by $100 million, raising total borrowing capacity to $600 million. The move followed use of an “accordion” feature, with other loan terms unchanged. Investors reacted cautiously amid thin year-end trading. The credit line is led by Bank of Oklahoma, Wells Fargo, Bank of America, U.S. Bank, and Associated Bank.
31 December 2025
GOOG stock edges lower after Alphabet insider sale filing, with year-end tech drag in focus

GOOG stock edges lower after Alphabet insider sale filing, with year-end tech drag in focus

Alphabet’s chief legal officer, John Kent Walker, sold 17,829 Class C shares worth about $5.6 million on Dec. 30, according to an SEC filing. GOOG slipped 0.04% to $314.43 in midday trading Wednesday, with Class A shares also down. The sale was made through a preset trading plan. Wall Street’s major indexes were slightly lower on the year’s final trading day.
31 December 2025
Palantir stock today: PLTR edges lower as Fed minutes and year-end trading test the AI rally

Palantir stock today: PLTR edges lower as Fed minutes and year-end trading test the AI rally

Palantir shares slipped 0.4% to $180.18 midday Wednesday, mirroring a modest drop in U.S. stocks after the Fed’s meeting minutes signaled a cautious 2026 rate outlook. Wedbush named Palantir a top AI pick for 2026 with a $230 target. The stock is up about 140% in 2025. Volume reached 8.8 million shares as investors awaited the next Fed meeting and Palantir’s earnings date.
Apple stock slips in year-end trading as tech drags; what investors watch next

Apple stock slips in year-end trading as tech drags; what investors watch next

Apple shares slipped 0.2% to $272.63 in late-morning trading on the final session of 2025, as investors trimmed exposure to large tech stocks. Microsoft and Broadcom also fell, while Nvidia gained. U.S. stocks drifted lower in thin holiday trading, with the Nasdaq-tracking QQQ down 0.3%. The Federal Reserve’s 2026 rate outlook and year-end positioning remained in focus.
Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab A/S shares fell 3.3% to $30.44 in New York after the company dropped further development of acasunlimab, a late-stage cancer drug, following a portfolio review. Genmab said the move does not affect its 2025 guidance and will focus on other pipeline drugs. The company also completed its acquisition of Merus N.V., paying $97 per share in a tender offer. Merus requested Nasdaq delist its stock after the merger.
Tesla stock today slips as TSLA braces for Q4 deliveries after Tesla posts analyst consensus

Tesla stock today slips as TSLA braces for Q4 deliveries after Tesla posts analyst consensus

Tesla shares slipped 0.2% to $453.58 late Wednesday morning as investors awaited the company’s quarterly deliveries report due Friday. Analyst consensus points to a 13% year-on-year drop in fourth-quarter deliveries, with estimates around 432,810 vehicles. South Korea’s L&F sharply reduced its battery-material supply deal with Tesla, citing lower business tied to Tesla’s battery program.

Stock Market Today

  • Australian Bank Shares Surge Amid Strong Lending but Future Gains Uncertain
    March 22, 2026, 9:22 PM EDT. Australian bank shares have surged between 21% and 38% over the past year, buoyed by solid half-year and quarterly results fueled by strong credit growth and fierce competition. Morgan Stanley's Australian research head, Richard Wiles, forecasts the robust lending environment, driven by business and mortgage loans, to continue for several more quarters. However, he warns that loan losses have bottomed out and further margin expansion is unlikely. Wiles cautions investors the banks may struggle to sustain current share price levels, raising questions about whether recent gains represent the peak of performance for the sector.
Go toTop